Concord has agreed to buy Hipgnosis Songs Fund, the troubled U.K.-based music royalties company, for $1.4 billion in cash, the firms announced this morning.
Why it matters: The deal ends months of uncertainty regarding the future of one of the music catalog market's biggest players.
